{"product_id":"clinical-problems-in-oncology-9781118673829","title":"Clinical Problems in Oncology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003ci\u003eClinical Problems in Oncology: A Practical Guide to Management\u003c\/i\u003e is an easy-to-use, compact\u003cbr\u003e reference with essential, practical information on managing oncological emergencies, as well as\u003cbr\u003e the side effects and complications of cancer and its treatment. Because patient responses can vary\u003cbr\u003e widely, depending on the type of treatment prescribed, this resource offers medical professionals\u003cbr\u003e the specific information they need to improve the evaluation and treatment of cancer patients at\u003cbr\u003e the point of care.\u003c\/p\u003e \u003cp\u003eThe compact format includes a wide range of clinical information, from the dose of drugs that would\u003cbr\u003e typically be used, through guidance on the practical procedures that are frequently used\u003cbr\u003e to treat oncology patients. Some of the book's highlights include:\u003c\/p\u003e \u003cp\u003e Toxicity grading and management, including at-a-glance summaries of the most common toxicities associated with chemotherapy\u003cbr\u003e  Prescribing guidelines, including how to write \u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e“Clinical Problems in Oncology: A Practical Guide to Management is an easy–to–use, compact reference with essential, practical information on managing oncological emergencies, as well as the side effects and complications of cancer and its treatment.”  (\u003ci\u003eKingbook73's Medical Ebook and Video Collection\u003c\/i\u003e, 7 October 2014)\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003ci\u003eList of contributors, ix\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePreface, xi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eAcknowledgements xii\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eList of abbreviations xiii\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Introduction to clinical problems in oncology 1\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSing Yu Moorcraft\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eGeneral approach to the management of oncology patients 2\u003c\/p\u003e \u003cp\u003ePerformance status 6\u003c\/p\u003e \u003cp\u003eTumour markers 6\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Oncological emergencies 13\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eDaniel L.Y. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAnaphylaxis and hypersensitivity reactions 13\u003c\/p\u003e \u003cp\u003eBleeding 16\u003c\/p\u003e \u003cp\u003eCentral airway obstruction and stridor 19\u003c\/p\u003e \u003cp\u003eExtravasation 23\u003c\/p\u003e \u003cp\u003eFebrile neutropenia 28\u003c\/p\u003e \u003cp\u003eHypercalcaemia 30\u003c\/p\u003e \u003cp\u003eNon-neutropenic sepsis 34\u003c\/p\u003e \u003cp\u003eRaised intracranial pressure and seizures 36\u003c\/p\u003e \u003cp\u003eSpinal cord compression 41\u003c\/p\u003e \u003cp\u003eSuperior vena cava obstruction 45\u003c\/p\u003e \u003cp\u003eTransfusion reactions 48\u003c\/p\u003e \u003cp\u003eTumour lysis syndrome 50\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Side effects and complications of cancer and its treatment 53\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAlexandra Pender, Sing Yu Moorcraft and Daniel L.Y. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview of toxicity management 54\u003c\/p\u003e \u003cp\u003eAbnormal liver function tests 57\u003c\/p\u003e \u003cp\u003eAlopecia 60\u003c\/p\u003e \u003cp\u003eAnaemia 62\u003c\/p\u003e \u003cp\u003eAnorexia and nutrition 66\u003c\/p\u003e \u003cp\u003eAscites 69\u003c\/p\u003e \u003cp\u003eBone metastases and osteoporosis 71\u003c\/p\u003e \u003cp\u003eBowel obstruction 75\u003c\/p\u003e \u003cp\u003eBreathlessness 77\u003c\/p\u003e \u003cp\u003eChest pain and other cardiac complications 81\u003c\/p\u003e \u003cp\u003eConfusion and decreased conscious level 86\u003c\/p\u003e \u003cp\u003eConstipation 91\u003c\/p\u003e \u003cp\u003eDental disorders 93\u003c\/p\u003e \u003cp\u003eDiarrhoea 95\u003c\/p\u003e \u003cp\u003eDysphagia 100\u003c\/p\u003e \u003cp\u003eFatigue 104\u003c\/p\u003e \u003cp\u003eFertility and pregnancy 106\u003c\/p\u003e \u003cp\u003eHaematuria 113\u003c\/p\u003e \u003cp\u003eHearing loss 115\u003c\/p\u003e \u003cp\u003eHiccups 117\u003c\/p\u003e \u003cp\u003eHyperglycaemia and hypoglycaemia 119\u003c\/p\u003e \u003cp\u003eHypertension and hypotension 123\u003c\/p\u003e \u003cp\u003eLymphoedema 127\u003c\/p\u003e \u003cp\u003eMucositis 129\u003c\/p\u003e \u003cp\u003eNausea and vomiting 133\u003c\/p\u003e \u003cp\u003eNeuropathy 138\u003c\/p\u003e \u003cp\u003eNeutropenia 142\u003c\/p\u003e \u003cp\u003eProteinuria 145\u003c\/p\u003e \u003cp\u003ePruritus 146\u003c\/p\u003e \u003cp\u003ePsychiatric disorders 149\u003c\/p\u003e \u003cp\u003eRash 154\u003c\/p\u003e \u003cp\u003eRenal failure and hydronephrosis 163\u003c\/p\u003e \u003cp\u003eSexual dysfunction 166\u003c\/p\u003e \u003cp\u003eThrombocytopenia 170\u003c\/p\u003e \u003cp\u003eThromboembolism 173\u003c\/p\u003e \u003cp\u003eVaccinations and immunoglobulin 178\u003c\/p\u003e \u003cp\u003eVisual symptoms 180\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Introduction to radiotherapy 185\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eEmma Dugdale, Alexandra Gilbert and Robin Prestwich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction to radiotherapy 185\u003c\/p\u003e \u003cp\u003eMethods of delivery of radiotherapy 186\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Radiotherapy side effects and their management 193\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAlexandra Gilbert, Emma Dugdale and Robin Prestwich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview of radiotherapy toxicity 193\u003c\/p\u003e \u003cp\u003eOverview of radical radiotherapy treatment and side effect management by anatomical treatment site 195\u003c\/p\u003e \u003cp\u003eBrain 195\u003c\/p\u003e \u003cp\u003eHead and neck 196\u003c\/p\u003e \u003cp\u003eBreast 200\u003c\/p\u003e \u003cp\u003eThorax 200\u003c\/p\u003e \u003cp\u003eAbdomen 204\u003c\/p\u003e \u003cp\u003ePelvis 205\u003c\/p\u003e \u003cp\u003eSkin toxicities 211\u003c\/p\u003e \u003cp\u003eTotal body irradiation 214\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Endocrine therapy, immunotherapy and targeted therapies 215\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSamantha Turnbull\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eEndocrine therapy 215\u003c\/p\u003e \u003cp\u003eImmunotherapy 218\u003c\/p\u003e \u003cp\u003eTargeted therapies 220\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Electrolyte abnormalities 225\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSing Yu Moorcraft\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHypocalcaemia 225\u003c\/p\u003e \u003cp\u003eHyperkalaemia and hypokalaemia 227\u003c\/p\u003e \u003cp\u003eHypermagnesaemia and hypomagnesaemia 231\u003c\/p\u003e \u003cp\u003eHypernatraemia and hyponatraemia 234\u003c\/p\u003e \u003cp\u003eHyperphosphataemia and hypophosphataemia 237\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Palliative care and pain management 241\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eKaren Neoh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePain management 241\u003c\/p\u003e \u003cp\u003eOverview of pain management 241\u003c\/p\u003e \u003cp\u003eOpioid prescribing in palliative care 245\u003c\/p\u003e \u003cp\u003eOpioid toxicity 251\u003c\/p\u003e \u003cp\u003eSyringe pumps 252\u003c\/p\u003e \u003cp\u003eEnd-of-life care 253\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Oncology procedures and their complications 257\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJuanita Lopez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAscitic drains (paracentesis) 257\u003c\/p\u003e \u003cp\u003eBiliary drains and stents 259\u003c\/p\u003e \u003cp\u003eCentral venous access devices 261\u003c\/p\u003e \u003cp\u003eChemoembolisation 265\u003c\/p\u003e \u003cp\u003eChest drains and pleurodesis 266\u003c\/p\u003e \u003cp\u003eEnteral feeding tubes 269\u003c\/p\u003e \u003cp\u003eNephrostomies and ureteric stents 270\u003c\/p\u003e \u003cp\u003eOesophageal stents and dilatation 272\u003c\/p\u003e \u003cp\u003eRadioembolisation (SIR-spheres®) 273\u003c\/p\u003e \u003cp\u003eRadiofrequency ablation (RFA) 275\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Cancer drug development and funding 277\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSing Yu Moorcraft\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical trials 277\u003c\/p\u003e \u003cp\u003eFunding of cancer drugs 280\u003c\/p\u003e \u003cp\u003ePersonalised medicine 282\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAppendices 287\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSing Yu Moorcraft and Daniel L.Y. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChemotherapy regimes 287\u003c\/p\u003e \u003cp\u003eDrug toxicities 287\u003c\/p\u003e \u003cp\u003eUseful resources 296\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIndex 301\u003c\/i\u003e\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406903255383,"sku":"9781118673829","price":65.66,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118673829.jpg?v=1730497503","url":"https:\/\/bookcurl.com\/products\/clinical-problems-in-oncology-9781118673829","provider":"Book Curl","version":"1.0","type":"link"}